Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human) Powder, For Solution
Product Images NDC 68982-182

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Wilate - Von Willebrand Factor/coagulation Factor Viii Complex (human) (NDC 68982-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Octapharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

This image shows a text panel presenting two dosing calculation formulas for von Willebrand Factor/Coagulation Factor VIII Complex (Human). The first formula calculates the required IU based on body weight and desired VWF:RCo rise. The second formula estimates the expected VWF:RCo rise percentage based on administered IU and body weight.*

FDA Label Image

Image File (Img0002)

A text panel displaying a dosing calculation example that involves units in international units per deciliter (IU/dL) and body weight in kilograms (kg), used for determining the loading dose in international units (IU). This is related to dosing of Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human) powder for solution for intravenous use.*

FDA Label Image

Image File (Img0003)

This image shows a text panel displaying mathematical formulas for calculating the required International Units (IU) of Factor VIII and the expected Factor VIII rise percentage in the blood. The formulas involve body weight in kilograms, desired Factor VIII rise percentage, and administered IU dosage.*

FDA Label Image

Image File (Img0004)

An instructional illustration showing the process of using a vial of diluent with another vial or container, likely part of the preparation for intravenous administration of Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human) powder for solution. The image depicts an arrow indicating the diluent being added to the vial.*

FDA Label Image

Image File (Img0005)

Illustration showing the assembly of a vial labeled "Diluent" with a vial adapter and a protective cap above it. This diagram likely demonstrates how to attach the adapter to the diluent vial as part of preparation for intravenous use.*

FDA Label Image

Image File (Img0006)

An instructional illustration displaying the assembly of a Wilate vial and a diluent container. The drawing shows the Wilate vial labeled visibly and a diluent bottle being attached above it, indicated by a downward arrow, demonstrating the proper connection for reconstitution of the powder for solution.*

FDA Label Image

Image File (Img0007)

An instructional diagram showing the assembly or connection of a Diluent container, positioned above, with the Wilate vial below. Arrows indicate the direction to connect or combine the two components, illustrating part of the preparation process for intravenous administration of Wilate powder for solution.*

FDA Label Image

Image File (Img0008)

A data table displaying virus reduction factors (log10 scale) for the manufacturing process of Wilate, listing reduction values for enveloped viruses (HIV-1a, SBV, BVDV, PRV) and non-enveloped viruses (REO-3, HAV, PPV) across different production steps including S/D Treatment, Ion-Exchange Chromatography, and TDH Treatment, with a summary Global Reduction Factor for each virus.*

FDA Label Image

Image File (Img0009)

A data table showing infusion counts and dose statistics (mean ± SD, range) for Wilate von Willebrand Factor/Coagulation Factor VIII Complex across different body locations. Data are separated for all subjects (n=45) and subjects aged 5-16 years (n=11), comparing initial and subsequent doses for locations including joints, epistaxis, GI tract, oral, gynecologic, and other sites.*

FDA Label Image

Image File (Img0010)

An instructional diagram showing a vial labeled "Diluent" below a container with a powder vial inside it. The illustration depicts the process of inserting the powder vial into the larger container, indicated by a downward arrow, likely demonstrating a step for reconstituting the drug powder with diluent.*

FDA Label Image

Image File (Img0011)

An instructional diagram labeled Figure 2 showing an assembly of a vial labeled 'Diluent' with a plastic vial adapter and a protective cap above it, depicting components required for preparing a solution from the vial contents.*

FDA Label Image

Image File (Img0012)

An instructional diagram illustrating how to connect the diluent vial to the Wilate vial. The image shows a diluent bottle positioned above the Wilate powder vial, with an arrow indicating attachment direction, demonstrating the preparation step for solution reconstitution prior to intravenous administration.*

FDA Label Image

Image File (Img0013)

An instructional diagram showing the assembly process of the Wilate vial and diluent bottle for intravenous use. The image illustrates the diluent bottle being inverted above the Wilate vial, with an arrow indicating connection or mixing between the two components.*

FDA Label Image

Image File (Img0014)

Label for Wilate von Willebrand Factor/Coagulation Factor VIII Complex (Human) powder for solution for intravenous injection. Contains 500 IU of von Willebrand factor and 500 IU of coagulation factor VIII. The label includes storage instructions, manufacturer Octapharma USA Inc, and NDC 68982-182-01.*

FDA Label Image

Img0015

Label for Wilate 1000 IU von Willebrand Factor/Coagulation Factor VIII Complex (Human) powder for solution for intravenous injection by Octapharma USA Inc. The label includes dosage strength, administration route, storage instructions, manufacturer and distributor information, and regulatory details. It states solvent detergent and heat treated, with no preservative, and cautions on storage temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.